September 20th 2024
The author discusses a program to prevent kidney decline and progression to dialysis by offering education, support services, and help navigating the health care system to those most at risk.
September 10th 2024
Precision Medicine Can Close Oncology Gaps—and Lead to “Doing Less”
December 20th 2021Physicians said it is in payers’ interest to use artificial intelligence to address social determinants of health, to cover tests, and to gather data. Doing so could let them stratify who needs certain screenings and diagnostic procedures and who doesn’t, which could lead to less consumption of health care.
Read More
Leveraging Data and AI to Connect the Life Sciences, Health Systems
December 20th 2021Today’s challenge, according to Microsoft's Iksha Herr, MS, is learning how to leverage artificial intelligence (AI) to process the waves of health care data and to drive insights that lead to better care delivery.
Read More
Digital Inhalers for COPD, Asthma Are Tantalizing but More Research Is Needed, Review Says
December 18th 2021Interest in the use of digital inhalers is growing, as they may provide real-world evidence about how patients monitor and treat their chronic obstructive pulmonary disease (COPD) and asthma at home, but additional questions need to be answered, according to a recent review.
Read More
Dr Leslie Kantor: Mild Flu Seasons Make Future Vaccine Matching Tricky
December 18th 2021When a flu season is mild, it can make developing a vaccine for the following season a bit more difficult as it can be hard to find the right match, but on the other hand, the US health system could benefit from less stress this winter given the unrelenting demands posed by COVID-19, says Leslie Kantor, PhD, MPH, chair and professor of the Department of Urban-Global Public Health, Rutgers School of Public Health.
Watch
Study Finds No Standardized Treatment, Continued Health Care Utilization in Pustular Psoriasis
December 18th 2021A case series of patients with pustular psoriasis indicated a lack of standardized treatment and continued health care utilization, in which men were at greater risk of an emergency department or hospital encounter.
Read More
Dr Daniel Greer Discusses the Evolution of CBT Capabilities in Chronic Insomnia
December 17th 2021Daniel Greer, PharmD, BCPP, clinical assistant professor, Rutgers Ernest Mario School of Pharmacy, speaks on how capabilities of cognitive behavioral therapy have evolved to a more user-friendly approach in the management of chronic insomnia.
Watch
What We're Reading: J&J Blood Clot Concerns; Abortion Pill Access; Pandemic Health Spending
December 17th 2021The CDC is recommending that people at risk of developing blood clots receive the Moderna or Pfizer/BioNTech vaccines instead of Johnson & Johnson (J&J); the FDA lifts restrictions on mail order access to abortion pills; US health care spending more than doubled during the first year of the pandemic.
Read More
Comorbid Psoriasis, NAFLD Linked With Significantly Impaired Kidney Function
December 15th 2021Patients with comorbid nonalcoholic fatty liver disease (NAFLD) and chronic plaque psoriasis were shown to have significantly lower estimated glomerular filtration rate levels and greater prevalence of more advanced chronic kidney disease.
Read More
Dr Frederick Locke on Real-World Implications of ZUMA-7 Findings in Relapsed/Refractory LBCL
December 13th 2021Frederick Locke, MD, vice chair, Department of Blood and Marrow Transplant and Cellular Immunotherapy Program, co-leader, Immuno-Oncology, Moffitt Cancer Center, discusses findings of the phase 3 ZUMA-7 trial presented at ASH 2021 and how use of axicabtagene ciloleucel can be optimally applied in a real-world setting.
Watch
Dr Sattva Neelapu: Axi-Cel Highly Effective as First-line Option in High-Risk Large B-Cell Lymphoma
December 13th 2021Sattva S. Neelapu, MD, professor and deputy department chair in the Department of Lymphoma/Myeloma in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center, discusses findings of the ZUMA-12 study examining axicabtagene ciloleucel (axi-cel) as a first-line treatment option for high-risk patients with large B-cell lymphoma.
Watch
Dr Mark Wildgust Reviews Key Cilta-Cel Research Presented at ASH 2021
December 13th 2021Mark Wildgust, PhD, vice president, Global Medical Affairs, Oncology, Janssen, speaks on progression-free survival, complete response, and overall survival benefits observed with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-1 and other studies presented at the 63rd Annual American Society of Hematology Meeting and Exposition.
Watch
Lori Muffly, MD, associate professor of medicine, Blood & Marrow Transplantation, Stanford University, discusses findings of her study showing disparities in clinical trial enrollment and patient outcomes for at-risk pediatric minority populations with acute lymphoblastic leukemia (ALL).
Watch
Uptake of Artificial Pancreas Systems in Primary Care Could Reduce Care Disparities
December 11th 2021Findings about the willingness of primary care providers to prescribe artificial pancreas systems have positive implications for increasing access to and reducing disparities around this technology by alleviating the need to see a specialist.
Read More
Using AI to Detect Early Signs of Parkinson Disease Through Facial Analysis
December 11th 2021Researchers at the University of Rochester are analyzing facial muscle movements through videos taken over webcams or smartphones to train a machine learning algorithm with the hope that it can predict Parkinson disease at an earlier stage.
Read More
Dr Andre Goy Previews Key Data on CAR T-Cell Therapy to Be Presented at ASH 2021
December 10th 2021Andre Goy, MD, MS, chairman and executive director of the John Theurer Cancer Center, provides an overview of the emerging data at ASH 2021 on CAR T-cell therapy as a second- and first-line treatment.
Watch
Pfizer predicts that a fourth dose of a COVID-19 vaccine may be needed to quell the Omicron variant; CMS officials share figures on enrollment for health coverage under the Affordable Care Act (ACA); City of Hope announces acquisition of Cancer Treatment Centers of America.
Read More
Patients With Psoriatic Disease May Have Greater Risk of VTE, PVD
December 6th 2021Patients with psoriasis were found to have a more than 20% increased risk of developing incident venous thromboembolism (VTE) and peripheral vascular disease (PVD), with notable at-risk groups including women and those with concomitant psoriatic arthritis.
Read More
What We’re Reading: Early Omicron Data; Average Young Adult Overweight; Vaccine Discrimination Risks
December 6th 2021Early data suggest the Omicron variant may cause less severe cases of COVID-19; a new JAMA study finds the average young adult overweight; spotlighting vaccine discrimination in Africa.
Read More
COVID-19 Not Creating Lingering Chronic Cough Impacts, Dr Peter Dicpinigaitis Says
December 6th 2021Peter Dicpinigaitis, MD, professor of medicine at the Albert Einstein College of Medicine and director of the Montefiore Cough Center, discusses what he and others have seen during the pandemic in patients with chronic cough who had COVID-19.
Watch